FDA Grants Pirtobrutinib Accelerated Approval for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Jaypirca (pirtobrutinib) is indicated for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who received at least two prior…
Properly Preparing for Tariffs and Other Supply Chain Obstacles In a video interview with Pharma Commerce, Jenna Dale, direct of client relations at Cencora, shares how pharmaceutical manufacturers are…
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation Image Credit: Adobe Stock Images/DouceFleur.com As some may be aware, rheumatoid arthritis (RA) is an inflammatory joint disease that can…